Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study.
about
Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies.Plasma tPA-Activity and Progression of Cerebral White Matter Hyperintensities in Lacunar Stroke Patients.The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial.Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up.
P2860
Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Signs of dysregulated fibrinol ...... s in a population-based study.
@ast
Signs of dysregulated fibrinol ...... s in a population-based study.
@en
type
label
Signs of dysregulated fibrinol ...... s in a population-based study.
@ast
Signs of dysregulated fibrinol ...... s in a population-based study.
@en
prefLabel
Signs of dysregulated fibrinol ...... s in a population-based study.
@ast
Signs of dysregulated fibrinol ...... s in a population-based study.
@en
P2093
P2860
P356
P1476
Signs of dysregulated fibrinol ...... s in a population-based study.
@en
P2093
Bernt Lindahl
Jan W Eriksson
Jan-Hakan Jansson
Jenny Hernestål-Boman
Margareta Norberg
Mats Eliasson
P2860
P2888
P356
10.1186/1475-2840-11-152
P407
P577
2012-12-18T00:00:00Z
P5875
P6179
1045796100